We Don’t Need Another Hero
نویسندگان
چکیده
منابع مشابه
We don't need another hero.
Everybody loves the stories of heroes like Martin Luther King, Jr., Mother Teresa, and Gandhi. But the heroic model of moral leadership usually doesn't work in the corporate world. Modesty and restraint are largely responsible for the achievements of the most effective moral leaders in business. The author, a specialist in business ethics, says the quiet leaders he has studied follow four basic...
متن کاملWe Don't Need Another Hero? The Impact of "Heroes" on Software Development
A software project has “Hero Developers” when 80% of contributions are delivered by 20% of the developers. Are such heroes a good idea? Are too many heroes bad for software quality? Is it better to have more/less heroes for different kinds of projects? To answer these questions, we studied 661 open source projects from Public open source software (OSS) Github and 171 projects from an Enterprise...
متن کاملWe Need Another Sputnik Moment!
The need for a qualified workforce in information technology and the broader science-technology fields, referred to as STEM (Science, Technology, Engineering and Mathematics) has reached crisis proportions. Native born U.S. students are not entering the STEM fields in college in sufficient numbers to avoid an impending technology-talent shortage. University enrollments are dwindling in the STEM...
متن کاملDo we need another Kt/V?
A new method of estimating Kt/V has been proposed. This was a required update to accommodate frequencies of dialysis other than thrice weekly [1].The original approximate method for calculating Kt/V from preand post-dialysis urea concentrations was developed using linear regression on a data set of measurements taken from patients undergoing thrice-weekly dialysis. The method assumes that the i...
متن کاملRosuvastatin: do we need another statin?
(1) Rosuvastatin (Crestor(TM)) is a new synthetic agent for the treatment and prevention of lipid disorders, a risk factor for coronary heart disease. (2) Rosuvastatin is undergoing phase III clinical trials. A New Drug Application was submitted to the U.S. Food and Drug Administration in June, 2001. No information on the regulatory status in Canada is currently available. (3) Limited evidence ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Commoning Ethnography
سال: 2020
ISSN: 2537-9879
DOI: 10.26686/ce.v3i1.6651